We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$7.65B
AUM Growth
-$508M
Cap. Flow
-$45.2M
Cap. Flow %
-0.59%
Top 10 Hldgs %
9.65%
Holding
2,519
New
638
Increased
627
Reduced
557
Closed
688

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$54.2M
2
CMS icon
CMS Energy
CMS
+$51.9M
3
NI icon
NiSource
NI
+$38.4M
4
NXST icon
Nexstar Media Group
NXST
+$36.3M
5
EXC icon
Exelon
EXC
+$35.6M

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$71.2M
2
FDX icon
FedEx
FDX
+$57.3M
3
CSL icon
Carlisle Companies
CSL
+$48.6M
4
BX icon
Blackstone
BX
+$42.7M
5
MPC icon
Marathon Petroleum
MPC
+$31.5M

Sector Composition

Rank Sector Weight
1 Industrials 14.49%
2 Technology 12.67%
3 Utilities 9.69%
4 Consumer Discretionary 9.33%
5 Energy 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUG icon
1376
Plug Power
PLUG
$3.2B
$491K 0.01%
23,348
-588,033
-96% -$14M
TFSL icon
1377
TFS Financial
TFSL
$4.98B
$490K 0.01%
37,689
+6,045
+19% +$85.7K
FL
1378
DELISTED
Foot Locker
FL
$489K 0.01%
+15,713
New +$502K
RXRX icon
1379
Recursion Pharmaceuticals
RXRX
$1.89B
$488K 0.01%
45,832
-146,241
-76% -$1.48M
HTH icon
1380
Hilltop Holdings
HTH
$2.21B
$486K 0.01%
19,566
-2,144
-10% -$58.3K
LGND icon
1381
Ligand Pharmaceuticals
LGND
$5.65B
$486K 0.01%
+9,044
New +$532K
SCI icon
1382
Service Corp International
SCI
$11.5B
$486K 0.01%
8,420
-196,124
-96% -$12.9M
TALK
1383
DELISTED
Talkspace
TALK
$483K 0.01%
469,337
-63,776
-12% -$93.6K
CNM icon
1384
Core & Main
CNM
$8.27B
$478K 0.01%
21,015
+4,362
+26% +$102K
TELL
1385
DELISTED
Tellurian Inc.
TELL
$475K 0.01%
198,780
+82,391
+71% +$297K
SYF icon
1386
Synchrony
SYF
$26B
$473K 0.01%
16,762
-74,685
-82% -$2.41M
FMS icon
1387
Fresenius Medical Care
FMS
$12.5B
$471K 0.01%
+33,541
New +$634K
HOLI
1388
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$471K 0.01%
27,530
+6,799
+33% +$114K
KYMR icon
1389
Kymera Therapeutics
KYMR
$10.4B
$469K 0.01%
+21,552
New +$568K
GCO icon
1390
Genesco
GCO
$373M
$468K 0.01%
11,909
+7,334
+160% +$392K
HLI icon
1391
Houlihan Lokey
HLI
$8.97B
$468K 0.01%
+6,209
New +$503K
RBLX icon
1392
Roblox
RBLX
$27.6B
$466K 0.01%
+13,012
New +$538K
NVAX icon
1393
Novavax
NVAX
$1.56B
$465K 0.01%
25,534
+4,238
+20% +$184K
ARAY icon
1394
Accuray
ARAY
$32.8M
$464K 0.01%
222,860
-172,224
-44% -$391K
FROG icon
1395
JFrog
FROG
$11.2B
$463K 0.01%
+20,925
New +$466K
TDW icon
1396
Tidewater
TDW
$4.59B
$463K 0.01%
+21,344
New +$455K
HI
1397
DELISTED
Hillenbrand
HI
$460K 0.01%
+12,537
New +$527K
ALG icon
1398
Alamo Group
ALG
$1.97B
$459K 0.01%
+3,755
New +$477K
FSS icon
1399
Federal Signal
FSS
$7.27B
$457K 0.01%
+12,239
New +$481K
ILPT
1400
Industrial Logistics Properties Trust
ILPT
$559M
$456K 0.01%
+82,847
New +$749K

Similar funds

Michael Gelband's Q3 2022 Portfolio in Review

As of Q3 2022, Michael Gelband held 2,519 positions worth $7.65B, down 6.2% from $8.16B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Michael Gelband's Q3 2022 filing shows 638 new, 627 increased, 557 reduced and 688 closed positions. Its largest new stake was Sun Communities: 212,831 shares worth $28.8M. The largest sale was Entergy, an estimated $71.2M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Utilities.

  • Michael Gelband's largest Q3 2022 buy was Sun Communities: 212,831 shares worth $28.8M.
  • Michael Gelband added most to EOG Resources in Q3 2022, an estimated $54.2M increase.
  • Michael Gelband's biggest Q3 2022 reduction was Entergy, cutting an estimated $71.2M.
  • Michael Gelband fully exited MACOM Technology Solutions in Q3 2022, selling an estimated $28.2M.
  • Michael Gelband's ten largest holdings make up 9.6% of its $7.65B portfolio in Q3 2022.
  • Michael Gelband opened 638 new positions and closed 688 in Q3 2022.
  • Michael Gelband's portfolio value fell 6.2% quarter-over-quarter to $7.65B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.